Clinical Evaluation Report (CER)

Clinical Evaluation Report (CER) - Axcellant

Clinical Evaluation Report (CER)

  1. lut 28, 2025

What Does 'Clinical Evaluation Report (CER)’ Mean?

A Clinical Evaluation Report (CER) is a comprehensive document that assesses the safety and performance of a medical device. It synthesizes and evaluates clinical data from various sources, including clinical investigations, literature reviews, and post-market surveillance, to demonstrate the device’s compliance with regulatory requirements.

CERs are crucial for obtaining and maintaining market approval for medical devices in many jurisdictions, particularly in the European Union. They provide a systematic analysis of the device’s benefits and risks, serving as a key component in the overall conformity assessment process for medical devices.

Why Is the 'Clinical Evaluation Report (CER)’ Important in Clinical Research?

Clinical Evaluation Reports (CERs) are crucial in clinical research as they provide a comprehensive assessment of a medical device’s safety and effectiveness. These reports play a vital role in regulatory decision-making, helping authorities determine whether a device meets the necessary standards for market approval and continued use.

CERs also serve as a valuable resource for healthcare professionals and researchers, offering a consolidated source of clinical evidence about a device. By systematically evaluating and presenting clinical data, CERs contribute to evidence-based medicine and help inform clinical practice, ultimately improving patient care and safety.

Good Practices and Procedures

  1. Conduct a thorough literature review, including both published and unpublished data, to ensure a comprehensive assessment of available clinical evidence.
  2. Develop a well-defined clinical evaluation plan that outlines the methods for data collection, analysis, and interpretation specific to the medical device.
  3. Utilize a risk-based approach to evaluate the clinical data, focusing on critical safety and performance aspects of the device.
  4. Implement a systematic method for grading the quality and relevance of individual studies included in the CER.
  5. Regularly update the CER to incorporate new clinical data and reflect changes in the device’s risk-benefit profile over time.

Related Terms

Read more

How clinical trials can become a strategic asset for biotech startups

Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…

Advancing PET Innovation at SNMMI 2025

Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…

Insights from Turku PET Symposium 2025

Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…